JP2017500316A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017500316A5 JP2017500316A5 JP2016539145A JP2016539145A JP2017500316A5 JP 2017500316 A5 JP2017500316 A5 JP 2017500316A5 JP 2016539145 A JP2016539145 A JP 2016539145A JP 2016539145 A JP2016539145 A JP 2016539145A JP 2017500316 A5 JP2017500316 A5 JP 2017500316A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- sdf
- condition
- medicament according
- msdf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361915842P | 2013-12-13 | 2013-12-13 | |
| US61/915,842 | 2013-12-13 | ||
| PCT/US2014/070010 WO2015089396A1 (en) | 2013-12-13 | 2014-12-12 | Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017500316A JP2017500316A (ja) | 2017-01-05 |
| JP2017500316A5 true JP2017500316A5 (enExample) | 2018-01-18 |
Family
ID=53371868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016539145A Pending JP2017500316A (ja) | 2013-12-13 | 2014-12-12 | ストロマ細胞由来因子−１のプロテアーゼ耐性変異体を用いた、組織損傷を修復する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20160303197A1 (enExample) |
| EP (1) | EP3079711A4 (enExample) |
| JP (1) | JP2017500316A (enExample) |
| KR (1) | KR20160096640A (enExample) |
| CN (1) | CN106029086A (enExample) |
| AU (1) | AU2014362198A1 (enExample) |
| CA (1) | CA2933620A1 (enExample) |
| IL (1) | IL246182A0 (enExample) |
| SG (1) | SG11201604793YA (enExample) |
| WO (1) | WO2015089396A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9308277B2 (en) | 2010-02-25 | 2016-04-12 | Mesoblast International Sàrl | Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| AU2012268078B2 (en) | 2011-06-07 | 2017-06-01 | Mesoblast International Sarl | Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived Factor-1 |
| US9035277B2 (en) | 2013-08-01 | 2015-05-19 | Taiwan Semiconductor Manufacturing Company, Ltd. | Semiconductor device and fabricating the same |
| WO2018183625A1 (en) * | 2017-03-30 | 2018-10-04 | Wake Forest University Health Sciences | Methods of treatment for kidney disease |
| EP3737437A4 (en) | 2018-01-10 | 2021-09-22 | Tufts Medical Center, Inc. | SYSTEMS AND METHODS FOR LEFT VENTRICULAR DISCHARGE IN THE TREATMENT OF A HEART ATTACK |
| TWI825446B (zh) * | 2020-08-14 | 2023-12-11 | 中國醫藥大學 | 醫藥組合物治療組織缺血狀況之用途 |
| WO2024243525A1 (en) * | 2023-05-24 | 2024-11-28 | Targazyyme, Inc. | Compositions, systems, and methods for combinatorial therapies containing fucosylated cells and chemokines and/or scaffolds for autoimmune conditions and regenerative medicine |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003901668A0 (en) * | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
| US20050271639A1 (en) * | 2002-08-22 | 2005-12-08 | Penn Marc S | Genetically engineered cells for therapeutic applications |
| US8516469B2 (en) * | 2005-07-25 | 2013-08-20 | Flexera Software Llc | Function binding method and system |
| US7696309B2 (en) * | 2006-10-23 | 2010-04-13 | The Brigham And Women's Hospital, Inc. | Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| US8095290B2 (en) * | 2008-08-01 | 2012-01-10 | GM Global Technology Operations LLC | Method to control vehicular powertrain by monitoring map preview information |
| US20110022413A1 (en) * | 2009-07-27 | 2011-01-27 | Welltrek International | Systems and methods for maintaining comprehensive medical records |
| US9308277B2 (en) * | 2010-02-25 | 2016-04-12 | Mesoblast International Sàrl | Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| AU2012268078B2 (en) * | 2011-06-07 | 2017-06-01 | Mesoblast International Sarl | Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived Factor-1 |
| CN104284976A (zh) * | 2012-03-06 | 2015-01-14 | Sct&B公司 | 胎盘干细胞及其分离方法与应用 |
-
2014
- 2014-12-12 SG SG11201604793YA patent/SG11201604793YA/en unknown
- 2014-12-12 CA CA2933620A patent/CA2933620A1/en not_active Abandoned
- 2014-12-12 EP EP14869229.6A patent/EP3079711A4/en not_active Withdrawn
- 2014-12-12 CN CN201480075473.6A patent/CN106029086A/zh active Pending
- 2014-12-12 WO PCT/US2014/070010 patent/WO2015089396A1/en not_active Ceased
- 2014-12-12 KR KR1020167017818A patent/KR20160096640A/ko not_active Withdrawn
- 2014-12-12 AU AU2014362198A patent/AU2014362198A1/en not_active Abandoned
- 2014-12-12 JP JP2016539145A patent/JP2017500316A/ja active Pending
- 2014-12-12 US US15/103,153 patent/US20160303197A1/en not_active Abandoned
-
2016
- 2016-06-13 IL IL246182A patent/IL246182A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017500316A5 (enExample) | ||
| Kasama et al. | Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction | |
| CN102718858B (zh) | 胰高血糖素样肽-1类似物单体、二聚体及其制备方法与应用 | |
| JPWO2019156137A5 (enExample) | ||
| US12465630B2 (en) | Small peptide compositions and uses thereof | |
| JP2014519514A5 (enExample) | ||
| JP2017500316A (ja) | ストロマ細胞由来因子−１のプロテアーゼ耐性変異体を用いた、組織損傷を修復する方法 | |
| CN110650747A (zh) | 用于治疗慢性肾病的杜拉鲁肽 | |
| AU2017213440A1 (en) | Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived Factor-1 | |
| Kwiecień et al. | Umbilical cord matrix (Wharton jelly) mesenchymal stem cells in Next-generation myocardial repair and regeneration: mechanisms and pre-clinical evidence | |
| JP2017517561A (ja) | 最適化ハムスターｒｅｇ３ガンマペプチドを利用する糖尿病を有する患者の間でのインスリン非依存性 | |
| US12146005B2 (en) | Compositions and methods for treatment of fungal infections | |
| RU2483750C1 (ru) | Способ лечения больных с острым инфарктом миокарда с подъемом сегмента st | |
| CN105079780B (zh) | 一种特异结合trb3的多肽在治疗腹主动脉瘤中的应用 | |
| Awada et al. | Factorial design of experiments to optimize multiple protein delivery for cardiac repair | |
| JP2020524132A5 (enExample) | ||
| JP2019512216A5 (enExample) | ||
| Kaufmann et al. | Endocrinology of the Heart | |
| AU2021294340B9 (en) | Compositions and methods for treatment of fungal infections | |
| JPWO2021262985A5 (enExample) | ||
| Ichiki et al. | P6528 Cardiorenal protection by subcutaneous cenderitide in experimental heart failure: a novel and safe therapeutic for humans with LVAD support | |
| CN106421754A (zh) | 白细胞介素33在制备治疗心肌炎疾病药物中的应用 | |
| TWI680139B (zh) | 短胜肽、及其組合物用於治療/預防糖尿病及與之相關疾病之用途 | |
| WO2006125200A2 (en) | Method for reducing sepsis or cardiogenic shock associated with myocardial injury | |
| CN104208660A (zh) | 低分子量碱性成纤维细胞生长因子lmw fgf2的应用 |